Complement C5a Receptors in Hidradenitis Suppurativa

NCT04251663 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2023-06-26

No results posted yet for this study

Summary

To study the role of C5a in Hidradenitis Suppurativa (HS). Complement C5a is a major chemotactic factor that stimulates neutrophil infiltration.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Kavita Y Sarin, MD PhD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-18
Primary Completion
2022-07-29
Completion
2022-07-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04251663 on ClinicalTrials.gov